Advertising, Testimonials, and a Discounted Referral Arrangement
Dr. Owen Pike launches a marketing campaign for his clinic. The website states: 'Our patented adjustment cures sciatica in 3 visits - 98% success rate.' The site features video testimonials from 5 patients, including one who says 'Dr. Pike fixed my herniated disc without surgery.' Dr. Pike also offers a 'friends and family' arrangement: any patient who refers a new patient receives $50 cash, and any local personal-injury attorney who refers a patient receives 10% of the collected fee. He offers a 'free first visit' coupon and advertises 'board-certified' even though he holds no board certification beyond his state license. A competitor complains to the Board.
1. Identify each advertising statement or arrangement that is likely to violate professional-conduct and fee-splitting rules, and explain why.
Read the worked answer
- 'Cures sciatica in 3 visits - 98% success rate' - A guarantee of cure and an unsubstantiated statistic. Advertising must not be false, deceptive, or misleading, and must not promise results. 'Patented' also implies a credential that should be verifiable.
- Testimonial claiming a herniated disc was 'fixed without surgery' - Patient testimonials that promise or imply superior results are risky; the claim is unverifiable and potentially misleading, and the patient's identity/consent must be protected.
- $50 cash per referral - Paying for patient referrals is a fee-splitting/inducement problem; compensation for referral of patients is generally prohibited.
- 10% of collected fee to referring attorneys - Classic fee-splitting: paying a percentage of professional fees to a non-provider referral source is prohibited and creates an improper financial incentive.
- 'Board-certified' when not certified - Misrepresentation of credentials is deceptive advertising.
- 'Free first visit' - Generally permissible as a discount if not deceptive and if the terms are clear; the problem is the bundled misleading claims, not the discount itself.
The reasoning: the rules target deception and improper financial incentives, not marketing per se. Each statement is tested against whether a reasonable patient could be misled or whether money is flowing for referrals rather than for services.
2. Dr. Pike argues the referral payments are 'just marketing' and the testimonials are 'true stories.' How should the Board analyze these defenses?
Read the worked answer
Referral payments: The label does not control. The test is whether compensation is being paid for the referral of patients rather than for bona fide services. $50 cash per patient and 10% of collected fees to attorneys are payments for referrals, which the fee-splitting prohibition targets because they compromise professional judgment and patient trust. 'Marketing' is not a defense to an inducement.
Testimonials: Truth of the individual story is not the standard. The standard is whether the advertisement as a whole is false, deceptive, or misleading and whether it promises results. A single true anecdote presented alongside '98% success' and 'cures' creates an overall misleading impression. Patient testimonials also raise confidentiality/consent issues - the patients must have authorized use of their statements and images.
The Board's focus is public protection: would a reasonable patient be induced to believe results are guaranteed, or that the doctor's judgment is for sale? If yes, the conduct is sanctionable regardless of literal truth of individual facts.
3. What corrective steps should Dr. Pike take, and what sanctions are plausible?
Read the worked answer
Corrective steps:
- Immediately remove or revise the cure/percentage claims, the misleading testimonial, and the 'board-certified' statement.
- Terminate the cash-per-referral and attorney percentage arrangements and recover/cease any payments.
- Obtain written patient authorizations for any testimonial retained.
- Implement a marketing review process and retain substantiation for any claims.
- Cooperate with the Board and self-report the corrections.
Plausible sanctions: reprimand, fine, required advertising-ethics CE, probation with marketing review, and restitution/disgorgement of referral payments. More severe outcomes (suspension) would be driven by persistence after warning, patient harm, or evidence the referral scheme actually influenced care.
The judgment point: the Board rewards prompt, complete remediation and treats ongoing deception or continued fee-splitting after notice as the aggravating factor.